Advanced

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

Jørgensen, Charlotte Levin Tykjær LU ; Bjerre, Christina; Ejlertsen, Bent; Bjerre, Karsten D.; Balslev, Eva; Bartels, Annette; Brünner, Nils and Nielsen, Dorte Lisbet (2014) In BMC Cancer 14.
Please use this url to cite or link to this publication:
author
publishing date
type
Contribution to journal
publication status
published
in
BMC Cancer
volume
14
publisher
BioMed Central
external identifiers
  • scopus:84904053589
ISSN
1471-2407
DOI
10.1186/1471-2407-14-360
language
English
LU publication?
no
id
285b058b-7e9c-478b-baf7-0d8bce975efc
date added to LUP
2017-04-18 14:33:45
date last changed
2017-07-23 05:27:15
@article{285b058b-7e9c-478b-baf7-0d8bce975efc,
  articleno    = {360},
  author       = {Jørgensen, Charlotte Levin Tykjær and Bjerre, Christina and Ejlertsen, Bent and Bjerre, Karsten D. and Balslev, Eva and Bartels, Annette and Brünner, Nils and Nielsen, Dorte Lisbet},
  issn         = {1471-2407},
  language     = {eng},
  publisher    = {BioMed Central},
  series       = {BMC Cancer},
  title        = {TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group},
  url          = {http://dx.doi.org/10.1186/1471-2407-14-360},
  volume       = {14},
  year         = {2014},
}